Kerr D, Cavan D A, Jennings B, Dunnington C, Gold D, Crick M
Bournemouth Diabetes and Endocrine Centre, Royal Bournemouth Hospital, UK.
Diabet Med. 1998 Oct;15(10):878-82. doi: 10.1002/(SICI)1096-9136(199810)15:10<878::AID-DIA686>3.0.CO;2-3.
Many screening methods are available for detecting diabetic retinopathy. However, once patients develop retinopathy, it is unclear as to what method should be used for their review. We describe a novel and integrated system for the screening and treatment of diabetic retinopathy using high street optometrists for primary screening and digital imaging as a secondary screening tool, with referral to a joint retinal clinic only where ophthalmological intervention may be required. Of 3586 patients screened by optometrists, 328 were classified as having moderate/severe pre-proliferative retinopathy or diabetic maculopathy. Patients with proliferative retinopathy (1% of the total) were recalled directly to the joint retinal clinic. A consecutive sample (281) of these patients, together with a further 100 classified by the optometrists as having no or background retinopathy were compared using digital images and standard 35 mm colour transparencies. These, together with the original optometrist reports, were reviewed independently and individually by an ophthalmologist. A further sample of 124 patients who had undergone both digital imaging and ophthalmologist slit-lamp examination were also compared. Comparison of 35 mm colour transparencies with optometrist reports showed the latter had a sensitivity for detecting sight-threatening retinopathy (STR) of 62%, a specificity of 84%, and a kappa score of 0.62. The results for digital images were 90%, 97%, and 0.90, respectively, although the extent of retinopathy was under-reported in 10 patients. With ophthalmologist slit-lamp examination as the gold standard, the sensitivity of digital imaging was 90% with a substantial level of agreement between them (kappa 0.61). We conclude that digital images provide an efficient method for the follow-up of patients with established or previously treated retinopathy.
有多种筛查方法可用于检测糖尿病视网膜病变。然而,一旦患者出现视网膜病变,尚不清楚应采用何种方法对其进行复查。我们描述了一种新颖的综合系统,用于糖尿病视网膜病变的筛查和治疗,该系统利用街边验光师进行初步筛查,并将数字成像作为二级筛查工具,仅在可能需要眼科干预时才转诊至联合视网膜诊所。在验光师筛查的3586例患者中,328例被归类为患有中度/重度增殖前期视网膜病变或糖尿病性黄斑病变。增殖性视网膜病变患者(占总数的1%)被直接召回联合视网膜诊所。对这些患者的连续样本(281例)以及另外100例被验光师归类为无视网膜病变或仅有背景性视网膜病变的患者,使用数字图像和标准35毫米彩色幻灯片进行了比较。这些图像以及原始的验光师报告由一位眼科医生独立且分别进行了复查。还对另外124例同时接受了数字成像和眼科医生裂隙灯检查的患者样本进行了比较。35毫米彩色幻灯片与验光师报告的比较显示,后者检测威胁视力的视网膜病变(STR)的灵敏度为62%,特异性为84%,kappa评分为0.62。数字图像的结果分别为90%、97%和0.90,不过有10例患者视网膜病变的程度报告不足。以眼科医生裂隙灯检查作为金标准,数字成像的灵敏度为90%,两者之间有较高程度的一致性(kappa 0.61)。我们得出结论,数字图像为已确诊或先前接受过治疗的视网膜病变患者的随访提供了一种有效的方法。